Arrowhead Research | Eget Kapital Och Reservfonder



Equity Capital And Reserves Ändra Datum
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Arrowhead Research USD 52.59M 132.85M 2024-12
Incyte USD 3.45B 276.41M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
Ligand Pharmaceuticals USD 830.44M 10.74M 2024-12
Merck USD 46.31B 1.81B 2024-12
Moderna USD 10.9B 1.03B 2024-12
Novartis USD 44.05B 605M 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
TG Therapeutics USD 222.36M 30.21M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Xencor USD 677.61M 46.22M 2024-12



Arrowhead Research Eget Kapital Och Reservfonder - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.